In the 1980s and 90s, pharmaceutical companies began  to market opioid painkillers aggressively, actively downplaying  their addictive potential to both the medical community  and the public.
En los años 80 y 90, empresas farmacéuticas comercializaron  analgésicos opioides contundentemente, restándole importancia  a su potencial adictivo tanto a la comunidad médica  como al público.